Agilent technologies INC:1109692 [21-002681] the lab requires agilent sureselect XT HS sequencing probes and kits (sole source) in order to sequence covid patients for arch mutations
Ended Purchase Order Awarded Last action
- Contract number
- 75N92021P00031
- Awardee
-
Agilent Technologies Inc. UEI SD9JZ9S7MEA6 Part of Agilent Technologies, Inc.
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,376
Award facts
- Contract value 100% obligated
- $5,376.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Marshallton, DE 19808, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$8,957 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $14,333 |
About this award
This federal contract award is for the purchase of AGILENT SURESELECT XT HS SEQUENCING PROBES AND KITS by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $5,376.00 firm fixed-price purchase order was awarded on November 30, 2020 to Agilent Technologies Inc., a global leader in life sciences and diagnostics instrumentation. The probes and kits are being used by the NHLBI lab to sequence COVID-19 patient samples for mutations. This award does not have a set-aside designation. Agilent Technologies Inc. is a subsidiary of the parent company Agilent Technologies, Inc., which is an established manufacturer of scientific equipment and has a history of providing analytical systems and services to various federal agencies.
Quick answers
Who was awarded contract 75N92021P00031?
75N92021P00031 was awarded to Agilent Technologies Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on November 30, 2020.
How much is contract 75N92021P00031 worth?
The government has obligated $5,376 on 75N92021P00031.
Was contract 75N92021P00031 competed?
The extent of competition for 75N92021P00031 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award